Roberts Brandi Insider Trades

Insider Trading History

Track insider trading activity for Roberts Brandi. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Definium Therapeutics
Definium Therapeutics DFTX
Chief Financial Officer
Holding Value $3.69M 150,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$24.59
Definium Therapeutics
Definium Therapeutics DFTX
Chief Financial Officer
Holding Value $12.3M 500,000 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$24.59
Mind Medicine
Mind Medicine MNMD
Chief Financial Officer
Holding Value $10.3M 500,000 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.63M 500,000 shares
$7.26
$20.69
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
Executive VP And CFO
Holding Value $0 0 shares
Last Trade
Dec 02, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$26.4M 439,660 shares
$59.98
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CFO
Holding Value $474k 7,900 shares
Last Trade
Oct 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 7,900 shares
$59.60
$59.98
Tff Pharmaceuticals
Tff Pharmaceuticals TFFP
Director
Holding Value $1.51k 23,165 shares
Last Trade
Jul 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 6,330 shares
$1.81
$0.06
Tff Pharmaceuticals
Tff Pharmaceuticals TFFP
Director
Holding Value $347 5,333 shares
Last Trade
Apr 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7k 5,333 shares
$3.14
$0.06
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CFO
Holding Value $5.43M 90,580 shares
Last Trade
Feb 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.75M 90,580 shares
$19.32
$59.98
Tff Pharmaceuticals
Tff Pharmaceuticals TFFP
Director
Holding Value $3.44k 52,858 shares
Last Trade
Dec 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$476k 52,858 shares
$9.00
$0.06
Tff Pharmaceuticals
Tff Pharmaceuticals TFFP
Director
Holding Value $1.3k 20,000 shares
Last Trade
Aug 15, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$205k 20,000 shares
$10.25
$0.06
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CFO
Holding Value $7.18M 119,700 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 119,700 shares
$4.35
$59.98
Tff Pharmaceuticals
Tff Pharmaceuticals TFFP
Director
Holding Value $1.36k 20,968 shares
Last Trade
Dec 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$440k 20,968 shares
$21.00
$0.06
Tff Pharmaceuticals
Tff Pharmaceuticals TFFP
Director
Holding Value $0 0 shares
Last Trade
Mar 25, 2022 Sale
$15.4M 95,000 shares
$162.00
$0.06
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CFO
Holding Value $5.4M 90,000 shares
Last Trade
Feb 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378k 90,000 shares
$4.20
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 11, 2021 Sale
No data
No data
$59.98
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
CFO & SVP Finance
Holding Value $746k 616,700 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$426k 616,700 shares
$0.69
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
CFO & Svp, Finance
Holding Value $6.05k 5,000 shares
Last Trade
Aug 13, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.05k 5,000 shares
$1.01
$1.21
Eterna Therapeutics
Eterna Therapeutics ERNA
CFO & Svp, Finance
Holding Value $1.23M 150,000 shares
Last Trade
Jun 30, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$341M 150,000 shares
$2,274.00
$8.19
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
CFO & Svp, Finance
Holding Value $182k 150,000 shares
Last Trade
Jun 30, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 150,000 shares
$1.10
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
CFO & Svp, Finance
Holding Value $605k 500,000 shares
Last Trade
Jan 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$540k 500,000 shares
$1.08
$1.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up